Literature DB >> 36110373

Chronic Lung and Respiratory Conditions Affecting Lungs and Airways.

Elena K Schneider-Futschik1.   

Abstract

Entities:  

Year:  2022        PMID： 36110373      PMCID： PMC9469184          DOI： 10.1021/acsptsci.2c00138

Source DB:  PubMed          Journal:  ACS Pharmacol Transl Sci        ISSN： 2575-9108


× No keyword cloud information.
  10 in total

Review 1.  IL-33 in Chronic Respiratory Disease: From Preclinical to Clinical Studies.

Authors:  Chantal Donovan; Philip M Hansbro
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-20

Review 2.  Emerging Cystic Fibrosis Transmembrane Conductance Regulator Modulators as New Drugs for Cystic Fibrosis: A Portrait of in Vitro Pharmacology and Clinical Translation.

Authors:  Drishti P Ghelani; Elena K Schneider-Futschik
Journal:  ACS Pharmacol Transl Sci       Date:  2019-10-02

Review 3.  Recent Advances in Molecular Diagnosis of Pulmonary Fibrosis for Precision Medicine.

Authors:  Mi Ho Jeong; Hongwei Han; David Lagares; Hyungsoon Im
Journal:  ACS Pharmacol Transl Sci       Date:  2022-07-20

4.  Toward the Next-Generation COVID-19 Vaccines That Circumvent Antigenic Drift while Defusing Viral Infection.

Authors:  Ariel Fernández
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-01

5.  Probing the Dynamic Structure-Function and Structure-Free Energy Relationships of the Coronavirus Main Protease with Biodynamics Theory.

Authors:  Hongbin Wan; Vibhas Aravamuthan; Robert A Pearlstein
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-06

6.  Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors.

Authors:  Chunlong Ma; Yanmei Hu; Julia Alma Townsend; Panagiotis I Lagarias; Michael Thomas Marty; Antonios Kolocouris; Jun Wang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-09

7.  Synergistic Inhibition of SARS-CoV-2 Replication Using Disulfiram/Ebselen and Remdesivir.

Authors:  Ting Chen; Cheng-Yin Fei; Yi-Ping Chen; Karen Sargsyan; Chun-Ping Chang; Hanna S Yuan; Carmay Lim
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-26

8.  Hybrid In Silico Approach Reveals Novel Inhibitors of Multiple SARS-CoV-2 Variants.

Authors:  Sankalp Jain; Daniel C Talley; Bolormaa Baljinnyam; Jun Choe; Quinlin Hanson; Wei Zhu; Miao Xu; Catherine Z Chen; Wei Zheng; Xin Hu; Min Shen; Ganesha Rai; Matthew D Hall; Anton Simeonov; Alexey V Zakharov
Journal:  ACS Pharmacol Transl Sci       Date:  2021-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.